Pieter Wyckmans > Quinz > Vilvoorde, Belgium > Lawyer Profile


Work Department

Life Sciences & Technology
Intellectual property


Pieter Wyckmans provides expert advice to companies and organizations active in the (bio-)pharmaceutical, biotech and smart devices sectors. He advises multinationals, SMEs, spin-offs and start-ups in (strategic) transactions, intellectual property matters and regulatory affairs. He has both years of experience as an M&A and commercial transactions lawyer and as in-house counsel of multinationals, particularly in the Life Sciences industry.


Founding partner at Quinz (since 2011); in-house counsel BASF and Engie; associate Linklaters and Loyens & Loeff


Dutch, French and English


Brussels Bar; Licensing Executive Society, European Centre for Clinical Research Training


  • Université de Montpellier, D.E.A. ‘Droits des Contrats d’Affaires’
  • Catholic University of Leuven (KU Leuven), LL.B. 1997 and JD 2000 (cum laude)

Lawyer Rankings

Belgium > Industry focus: Healthcare and life sciences

(Leading individuals)

Pieter WyckmansQuinz

Considered as a ‘one-stop firm in Belgium for healthcare matters‘, Quinz‘s life sciences and technology practice is co-headed by the ‘smart, business-minded and solution-driven Olivier Van Obberghen and Pieter Wyckmans, who is recognised as ‘top notch in healthcare regulatory matters‘. The team’s workload typically includes the drafting and negotiation of licensing contracts, assisting on antitrust and data privacy compliance matters, and advising on clinical development, market access, pricing and reimbursement distribution. Senior associate Marion Lapage ‘is a very gifted transactional lawyer‘.

Comparative Guides

Belgium: Pharmaceutical Advertising November 2020 This country-specific Q&A provides an overview to Pharmaceutical Advertising laws and regulations that may occur in Belgium.